To Assess the Protective Effect of the Fixed Drug Combination of Disodium Cromoglycate Plus Reproterol
NCT00777348
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
62
Enrollment
INDUSTRY
Sponsor class
Conditions
Asthma, Exercise-Induced
Interventions
DRUG:
Combination DSCG and Reproterol
Sponsor
MEDA Pharma GmbH & Co. KG
Collaborators
[object Object]
[object Object]